News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,573 Results
Type
Article (40209)
Company Profile (253)
Press Release (657111)
Section
Business (204861)
Career Advice (2023)
Deals (35465)
Drug Delivery (94)
Drug Development (81123)
Employer Resources (170)
FDA (16184)
Job Trends (14900)
News (346048)
Policy (32585)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2590)
Academic (1)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49644)
ALS (79)
Alzheimer's disease (1332)
Antibody-drug conjugate (ADC) (99)
Approvals (16172)
Artificial intelligence (217)
Autoimmune disease (11)
Automation (14)
Bankruptcy (361)
Best Places to Work (11664)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (180)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1836)
Cardiovascular disease (139)
Career advice (1684)
Career pathing (29)
CAR-T (134)
Cell therapy (381)
Cervical cancer (14)
Clinical research (65576)
Collaboration (722)
Compensation (419)
Complete response letters (18)
COVID-19 (2591)
CRISPR (34)
C-suite (192)
Cystic fibrosis (97)
Data (1778)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (228)
Diagnostics (6335)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (108)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (70)
Earnings (85958)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111714)
Executive appointments (609)
FDA (17186)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (652)
Gene editing (92)
Generative AI (18)
Gene therapy (265)
GLP-1 (665)
Government (4395)
Grass and pollen (4)
Guidances (47)
Healthcare (18823)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (93)
Indications (24)
Infectious disease (2713)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (73)
Interviews (314)
IPO (16496)
IRA (40)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (9)
Labor market (30)
Layoffs (445)
Leadership (15)
Legal (7912)
Liver cancer (71)
Lung cancer (267)
Lymphoma (125)
Machine learning (2)
Management (58)
Manufacturing (254)
MASH (58)
Medical device (13325)
Medtech (13330)
Mergers & acquisitions (19395)
Metabolic disorders (596)
Multiple sclerosis (62)
NASH (16)
Neurodegenerative disease (71)
Neuropsychiatric disorders (23)
Neuroscience (1777)
NextGen: Class of 2025 (6530)
Non-profit (4505)
Northern California (2276)
Now hiring (36)
Obesity (328)
Opinion (197)
Ovarian cancer (61)
Pain (71)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (17)
Patents (186)
Patient recruitment (86)
Peanut (45)
People (57279)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20448)
Phase II (28875)
Phase III (21502)
Pipeline (853)
Podcasts (41)
Policy (104)
Postmarket research (2568)
Preclinical (8631)
Press Release (68)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (343)
Real estate (5960)
Recruiting (65)
Regulatory (22098)
Reports (43)
Research institute (2356)
Resumes & cover letters (351)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (116)
Series B (71)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1967)
Special edition (14)
Sponsored (28)
Startups (3593)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (25)
United States (20040)
Vaccines (643)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (31)
Worklife (14)
Date
Today (53)
Last 7 days (578)
Last 30 days (2913)
Last 365 days (33903)
2025 (6476)
2024 (35263)
2023 (40140)
2022 (51244)
2021 (55810)
2020 (54207)
2019 (46687)
2018 (35176)
2017 (32279)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (721)
Alabama (48)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37837)
Australia (6184)
California (5209)
Canada (1803)
China (427)
Colorado (237)
Connecticut (251)
Delaware (119)
Europe (81139)
Florida (773)
Georgia (182)
Idaho (57)
Illinois (470)
India (22)
Indiana (281)
Iowa (7)
Japan (131)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (798)
Massachusetts (3938)
Michigan (206)
Minnesota (354)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1482)
New Mexico (28)
New York (1491)
North Carolina (883)
North Dakota (7)
Northern California (2276)
Ohio (181)
Oklahoma (13)
Oregon (33)
Pennsylvania (1183)
Puerto Rico (7)
Rhode Island (24)
South America (1102)
South Carolina (16)
South Dakota (1)
Southern California (1967)
Tennessee (88)
Texas (768)
Utah (160)
Virginia (123)
Washington D.C. (56)
Washington State (495)
West Virginia (3)
Wisconsin (47)
697,573 Results for "alerion biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Impact BioMedical Inc. to Present at The Microcap Conference
January 23, 2025
·
1 min read
Press Releases
Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025
March 5, 2025
·
2 min read
Press Releases
First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to Revolutionize Cancer Treatment
January 13, 2025
·
4 min read
Press Releases
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
February 27, 2025
·
2 min read
Partnered
Making the Grade: Drexel’s Biomedical Sciences Programs Boost Careers at All Stages
At Drexel University’s Graduate School of Biomedical Sciences and Professional Studies, graduate students and active professionals can take interdisciplinary, career-oriented programs designed to help launch their careers and take them to the next level.
December 3, 2024
·
5 min read
·
BioSpace Insights
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Business
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
September 16, 2024
·
2 min read
Press Releases
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
November 25, 2024
·
5 min read
Business
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
September 17, 2024
·
2 min read
1 of 69,758
Next
